All active Physician roles based in France.
Pick a job to read the details
Tap any role on the left — its description and apply link will open here.
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Senior Director, Commercial, France is responsible for defining and executing the local commercial strategy for oncology products. This role is accountable for building the commercial organization, driving launch and growth performance, and ensuring strong alignment across Medical Affairs, Market Access, and other key functions.
The incumbent needs to proactively recognize and address relevant systemic (e.g. health care structures, competitors, data gaps, diagnostic challenges, missing advocacy) and HCP related opportunities (e.g. therapeutic gaps, differentiation, economical attributes, clear messaging of patient- and physician relevant benefits). The Senior Director Commercial will further oversee the generation of insights from the therapeutic field, and translate these insights into a comprehensive, cross-functional strategy. Supporting a clear positioning and aligned communication approach, the incumbent will in addition secure the development and implementation of tactics and tools for the field force to effectively address customer needs.
Responsibilities:
Act as the Commercial Lead for France accountable for local commercial strategy, execution, and performance across the oncology portfolio.
Serve as a core member of the France Leadership Team, contributing France strategy, launch planning, and business decisions.
Partner with regional and local Medical Affairs and Marketing Team to translate clinical and economic evidence into compelling value communications tailored for France stakeholders including HCPs and payers.
Translate regional commercial strategy into locally optimized plans aligned with market dynamics, customer needs, and healthcare system requirements.
Translate regional commercial strategy into locally optimized plans aligned with market dynamics, customer needs, and healthcare system requirements in close collaboration with the ED Marketing, Europe.
Collaborate with regional commercial teams by representing the country and contributing to commercial plans shaping our strategy.
Develop and execute country-level brand and portfolio strategies across pre-launch, launch, and post-launch phases.
Drive demand generation and appropriate use through non-promotional and promotional channels in compliance with local regulations.
Lead forecasting, budgeting, and operational planning for the country in close collaboration with the ED, Commercial Excellence, Business Analytics and Insights, Europe.
Lead commercial launch readiness for oncology products, including customer strategy, segmentation, targeting, and field force planning.
Partner closely with Medical Affairs and Market Access to ensure integrated launch execution and consistent external engagement.
Monitor performance, competitive dynamics, and market trends, adjusting strategy as needed.
Oversee customer engagement strategy across key stakeholders, including oncologists, treatment centers, and healthcare organizations.
Ensure effective field force deployment and capability building (e.g., sales, key account management, customer-facing roles).
Work closely with Medical Affairs, Market Access, Regulatory, Finance, Corporate Affairs and other support functions to ensure aligned and compliant country execution.
Ensure strong integration of commercial plans with access, medical, and evidence strategies.
Build, lead, and develop the country commercial organization, including sales, marketing, and customer-facing roles as the business scales.
Establish commercial processes, governance, and ways of working as part of the country build-out.
Foster a culture of accountability, collaboration, and performance excellence.
Contribute to regional and country-specific initiatives.
Travel nationally and internationally.
Required Skills, Experience and Education:
Advanced degree required (e.g., MSc, PhD, MD, PharmD).
10+ years of experience in pharmaceutical or biotech commercial roles.
Significant experience in oncology commercial leadership at country level.
Proven track record of successful oncology product launches in France and successful HCP / KOL interactions.
Proven project management experience.
Excellent communication skills, both in person and virtual.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Experience in a US-based or global biotech and/or in a build-out or first-in-country role strongly preferred.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial commercial environment.
High capacity of social competence for teamwork, coaching and situational leadership.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-MP1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
Reporting to the VP, General Manager, France the Senior Director, Medical Affairs, France is the medical leader responsible for defining and executing the local medical strategy for oncology products. This role serves as the medical voice within the French Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs.
This leader will ensure that French medical considerations are embedded in the regional medical strategy and plans and will partner with the General Manager and crossfunctional teams, as well as the VP, Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the French medical team and work closely with the Global and Regional Medical Affairs teams across Med Affairs functions.
Responsibilities:
Act as the Medical Affairs lead for France, accountable for local medical strategy, execution, and impact across the oncology portfolio.
Translate global medical and clinical strategies into locally relevant medical plans aligned with French regulations and clinical practice.
Build and maintain strong relationships with national and regional key opinion leaders, oncology networks, academic institutions, and scientific societies.
Lead scientific exchange, advisory boards, investigator and other external meetings, press conferences, and congress engagement at country level.
Serve as medical expert within the local oncology and scientific community, acting as a spokesperson for France.
Collaborate effectively with regional and global teams by contributing to overall medical affairs strategy, strongly partnering with local, regional and global clinical development and operations teams.
Drive local medical strategy across pre-launch, launch, and post-launch phases.
Provide local medical expertise on evidence generation activities including local studies, real-world evidence initiatives, and investigator-initiated research (where permitted).
Ensure effective execution of publication plans and scientific communication activities.
Lead medical launch readiness for oncology products, including training, scientific materials, and field medical engagement plans.
Partner with Market Access and Commercial teams to support value communication and reimbursement-related interactions from a medical perspective, e.g. representing and defining evidence and value of innovation at oral HTA hearings.
Support lifecycle management activities including new indications, label updates, and competitive positioning.
Work closely with Market Access, Commercial, Regulatory, Safety, and Corporate Affairs teams to ensure aligned and compliant execution of country plans.
Provide medical review and approval of non-promotional materials in accordance with local regulations and company policies.
Build, lead, and develop the French Medical Affairs team, including Medical Directors and Medical Science Liaisons.
Establish medical processes, governance, and ways of working as part of the french build-out.
Foster a culture of scientific rigor, compliance, and collaboration.
Ensure all medical activities comply with local regulations, national and EFPIA codes, and internal company policies.
Represent Medical Affairs in french governance and risk management forums.
Required Skills, Experience and Education:
Advanced degree required (MD, PhD, or PharmD).
Strong background and experience in oncology required.
10+ years’ experience in Medical Affairs with a track record of country leadership.
Proven value and benefit assessment experience, with deep understanding of country payer decision-making.
Strong stakeholder management and ability to collaborate with internal and external partners.
Proven experience supporting oncology product launches in a European market.
Strong understanding of the local healthcare system, clinical practice, and regulatory environment.
Experience in a US-based or global biotech and/or in a build-out or first-in-country role strongly.
Excellent communication skills, both in person and virtual.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial environment.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-MP1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Location: Paris or Strasbourg, France, with the ability to commute 2 days per week to one or both cities
Commitment: Full-time
Start Date: June 2026
Package: Market-competitive salary for early-stage startups, plus performance bonus and milestone-based equity
AIDO is an early-stage medical robotics venture on a mission to transform the fight against cancer through innovation in robotic endoscopy. Originating from the world-renowned IHU Strasbourg, the company is developing a novel robotic “third hand” add-on for flexible endoscopes. This compact and intuitive electromechanical assistant enhances the performance of therapeutic endoscopic procedures.
AIDO’s proprietary technology improves ergonomics, stability, and instrument control, reducing the physical strain and coordination burden typically placed on endoscopists. By making complex therapeutic procedures easier, more reproducible, and more comfortable to perform, AIDO enables physicians to treat cancers and pre-cancerous lesions endoscopically rather than surgically, supporting earlier and non-invasive intervention for patients.
Validated by more than 60 clinicians, AIDO is now entering a pivotal phase, industrializing its prototype into a clinical-grade medical device, advancing regulatory pathways, and shaping future AI-enabled capabilities.
AIDO is seeking a hands-on CTO / Head of Engineering who can lead product development end-to-end, establish the engineering foundation of the company, and drive the technical roadmap as it enters a new phase of growth.
This role combines strategic influence with deep technical execution. The successful candidate will work closely with suppliers, clinicians, and the CEO to bring a safe, intuitive, and robust device to market.
NLC Health Ventures is a leading healthtech and biotech innovation platform based in Amsterdam, combining venture building and fund management across Europe and North America. With 40-45 employees, NLC manages four captive funds investing in ventures from pre-seed to Series B-C, and is fundraising for a fifth fund. The funds have a diverse LP base and are invested in over 70 companies. NLC values a collaborative, open, and impact-driven culture, where team members’ ideas and contributions truly matter.
Ready to apply?
Apply to CAREERS AT NLCCookies & analytics
This site uses cookies from third-party services to deliver its features and to analyze traffic.